论文信息 - Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status. - 字舞流文

Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status.

B. Venmans | A. van der Wekken | A. ten Brinke | A. Brinke | W. V. van Geffen | K. Jong | W. H. V. Geffen | F. V. van Vollenhoven | A. Wekken | Rolof G. P. Gijtenbeek | F. Vollenhoven | W. H. van Geffen | Kim de Jong | R. Gijtenbeek